Literature DB >> 19104049

Variation in dopamine genes influences responsivity of the human reward system.

Jean-Claude Dreher1, Philip Kohn, Bhaskar Kolachana, Daniel R Weinberger, Karen Faith Berman.   

Abstract

In humans, dopamine neurotransmission is influenced by functional polymorphisms in the dopamine transporter (DAT1) and catechol-O-methyltransferase (COMT) genes. Here, we used event-related functional magnetic resonance imaging to directly investigate the neurofunctional effects of the Val(158)Met COMT and variable number of tandem repeat DAT1 polymorphisms on distinct components of the reward system in humans. The results revealed a main effect of COMT genotype in the ventral striatum and lateral prefrontal cortex during reward anticipation (P < 0.001, uncorrected) and in the orbitofrontal cortex at the time of reward delivery (P < 0.005), met/met individuals exhibiting the highest activation. The main effect of DAT1 genotype was seen in robust blood-oxygen-level-dependent response differences in the caudate nucleus and ventral striatum during reward anticipation (P < 0.001) and in the lateral prefrontal cortex and midbrain at the time of reward delivery, with carriers of the DAT1 9-repeat allele showing the highest activity. Moreover, an interaction between the COMT and DAT1 genes was found in the ventral striatum and lateral prefrontal cortex during reward anticipation and in the lateral prefrontal and orbitofrontal cortices as well as in the midbrain at the time of reward delivery, with carriers of the DAT1 9-repeat allele and COMT met/met allele exhibiting the highest activation, presumably reflecting functional change consequent to higher synaptic dopamine availability. Taken together, these results indicate that genetically influenced variations in dopamine transmission modulate the response of brain regions involved in anticipation and reception of rewards and suggest that these responses may contribute to individual differences in reward-seeking behavior and in predisposition to neuropsychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19104049      PMCID: PMC2626752          DOI: 10.1073/pnas.0805517106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  The human genome: mutations.

Authors:  Michael Egan; David Goldman; Daniel Weinberger
Journal:  Am J Psychiatry       Date:  2002-01       Impact factor: 18.112

2.  Neural responses during anticipation of a primary taste reward.

Authors:  John P O'Doherty; Ralf Deichmann; Hugo D Critchley; Raymond J Dolan
Journal:  Neuron       Date:  2002-02-28       Impact factor: 17.173

3.  A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: characterization with rapid event-related fMRI.

Authors:  Brian Knutson; Grace W Fong; Shannon M Bennett; Charles M Adams; Daniel Hommer
Journal:  Neuroimage       Date:  2003-02       Impact factor: 6.556

4.  Genotype influences in vivo dopamine transporter availability in human striatum.

Authors:  A Heinz; D Goldman; D W Jones; R Palmour; D Hommer; J G Gorey; K S Lee; M Linnoila; D R Weinberger
Journal:  Neuropsychopharmacology       Date:  2000-02       Impact factor: 7.853

5.  Effect of dopamine uptake inhibition on brain catecholamine levels and locomotion in catechol-O-methyltransferase-disrupted mice.

Authors:  Marko Huotari; Miklos Santha; Louis R Lucas; Maria Karayiorgou; Joseph A Gogos; Pekka T Männistö
Journal:  J Pharmacol Exp Ther       Date:  2002-12       Impact factor: 4.030

6.  Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR.

Authors:  Jonathan Mill; Philip Asherson; Clare Browes; Ursula D'Souza; Ian Craig
Journal:  Am J Med Genet       Date:  2002-12-08

7.  Prediction of dopamine transporter binding availability by genotype: a preliminary report.

Authors:  L K Jacobsen; J K Staley; S S Zoghbi; J P Seibyl; T R Kosten; R B Innis; J Gelernter
Journal:  Am J Psychiatry       Date:  2000-10       Impact factor: 18.112

8.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

Authors:  M F Egan; T E Goldberg; B S Kolachana; J H Callicott; C M Mazzanti; R E Straub; D Goldman; D R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

9.  COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor.

Authors:  Jon-Kar Zubieta; Mary M Heitzeg; Yolanda R Smith; Joshua A Bueller; Ke Xu; Yanjun Xu; Robert A Koeppe; Christian S Stohler; David Goldman
Journal:  Science       Date:  2003-02-21       Impact factor: 47.728

10.  Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function.

Authors:  M Matsumoto; C Shannon Weickert; M Akil; B K Lipska; T M Hyde; M M Herman; J E Kleinman; D R Weinberger
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

View more
  160 in total

Review 1.  The behavioral activation system and mania.

Authors:  Sheri L Johnson; Michael D Edge; M Kathleen Holmes; Charles S Carver
Journal:  Annu Rev Clin Psychol       Date:  2011-11-07       Impact factor: 18.561

2.  Caudate Volume in Offspring at Ultra High Risk for Alcohol Dependence: COMT Val158Met, DRD2, Externalizing Disorders, and Working Memory.

Authors:  Shirley Y Hill; Sarah Lichenstein; Shuhui Wang; Howard Carter; Michael McDermott
Journal:  Adv J Mol Imaging       Date:  2013-10-01

3.  Effect of dopamine transporter genotype on intrinsic functional connectivity depends on cognitive state.

Authors:  Evan M Gordon; Melanie Stollstorff; Joseph M Devaney; Stephanie Bean; Chandan J Vaidya
Journal:  Cereb Cortex       Date:  2011-11-02       Impact factor: 5.357

4.  Parental education predicts corticostriatal functionality in adulthood.

Authors:  Peter J Gianaros; Stephen B Manuck; Lei K Sheu; Dora C H Kuan; Elizabeth Votruba-Drzal; Anna E Craig; Ahmad R Hariri
Journal:  Cereb Cortex       Date:  2010-09-01       Impact factor: 5.357

5.  The environment and schizophrenia.

Authors:  Jim van Os; Gunter Kenis; Bart P F Rutten
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

6.  Striatal sensitivity during reward processing in attention-deficit/hyperactivity disorder.

Authors:  Yannis Paloyelis; Mitul A Mehta; Stephen V Faraone; Philip Asherson; Jonna Kuntsi
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-06-05       Impact factor: 8.829

7.  The effects of methylphenidate on cerebral responses to conflict anticipation and unsigned prediction error in a stop-signal task.

Authors:  Peter Manza; Sien Hu; Jaime S Ide; Olivia M Farr; Sheng Zhang; Hoi-Chung Leung; Chiang-shan R Li
Journal:  J Psychopharmacol       Date:  2016-01-11       Impact factor: 4.153

Review 8.  Applying imaging genetics to ADHD: the promises and the challenges.

Authors:  Zhaomin Wu; Li Yang; Yufeng Wang
Journal:  Mol Neurobiol       Date:  2014-04-01       Impact factor: 5.590

9.  Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.

Authors:  Joseph P Schacht; Raymond F Anton; Konstantin E Voronin; Patrick K Randall; Xingbao Li; Scott Henderson; Hugh Myrick
Journal:  Neuropsychopharmacology       Date:  2012-10-03       Impact factor: 7.853

10.  Effects of a GWAS-Supported Schizophrenia Variant in the DRD2 Locus on Disease Risk, Anhedonia, and Prefrontal Cortical Thickness.

Authors:  Margarita V Alfimova; Nikolay V Kondratyev; Alexander S Tomyshev; Irina S Lebedeva; Tatyana V Lezheiko; Vasiliy G Kaleda; Lilia I Abramova; Vera E Golimbet
Journal:  J Mol Neurosci       Date:  2019-05-03       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.